Induced Pluripotent Stem Cells (iPSCs)
The discovery in 2006 that human and mouse fibroblasts could be reprogrammed to generate induced pluripotent stem cells (iPSCs) with qualities remarkably similar to embryonic stem cells has created a valuable new source of pluripotent cells for drug discovery, cell therapy, and basic research.
Invitrogen™ products have been an integral part of iPSC research from the initial discovery of iPSCs to current breakthroughs. Our broad technology platform provides optimized tools for each step of the iPSC workflow: from reprogramming somatic cells to iPSC expansion, validation, and differentiation.
Step-by-Step Guide to iPSC Research Products
Reprogramming of somatic cells for Induced Pluripotent Stem cell (iPS cell) generation can be accomplished by a number of technologies.
Life Technologies provides traditional and non-integrating tools for iPSC generation from a range of somatic cell types.
Cell Identity Confirmation